MY146275A - 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives - Google Patents

4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives

Info

Publication number
MY146275A
MY146275A MYPI20083110A MYPI20083110A MY146275A MY 146275 A MY146275 A MY 146275A MY PI20083110 A MYPI20083110 A MY PI20083110A MY PI20083110 A MYPI20083110 A MY PI20083110A MY 146275 A MY146275 A MY 146275A
Authority
MY
Malaysia
Prior art keywords
methylaminoquinazoline
benzoylaminophenyl
dimethoxy
derivatives
optionally substituted
Prior art date
Application number
MYPI20083110A
Inventor
Miyazaki Kazuki
Kusano Kazutomi
Takase Yasutaka
Asano Osamu
Shirato Manabu
Wakita Hisashi
Ishii Naoto
Saeki Takao
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MY146275A publication Critical patent/MY146275A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A COMPOUND REPRESENTED BY THE FOLLOWING FORMULA (I), SALT THEREOF, OR HYDRATE THEREOF, CAN EFFECTIVELY RELIEVE ITCH CAUSED BY ATOPIC DISEASE OR THE LIKE: WHEREIN R REPRESENTS HYDROXYL,C??? ALKOXY OPTIONALLY SUBSTITUTED WITH C??? ALKOXY, OR AMINO OPTIONALLY SUBSTITUTED WITH C??? ALKYL.
MYPI20083110A 2006-02-21 2007-02-20 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives MY146275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
MY146275A true MY146275A (en) 2012-07-31

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20083110A MY146275A (en) 2006-02-21 2007-02-20 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives

Country Status (18)

Country Link
JP (1) JP4778550B2 (en)
KR (1) KR101278852B1 (en)
AT (1) ATE517875T1 (en)
BR (1) BRPI0708098B8 (en)
CY (1) CY1112554T1 (en)
DK (1) DK1992622T3 (en)
ES (1) ES2368089T3 (en)
HK (1) HK1122025A1 (en)
HR (1) HRP20110604T1 (en)
IL (1) IL193322A (en)
JO (1) JO2726B1 (en)
MY (1) MY146275A (en)
NZ (1) NZ569936A (en)
PT (1) PT1992622E (en)
RS (1) RS51969B (en)
RU (1) RU2431632C2 (en)
SI (1) SI1992622T1 (en)
TW (1) TWI404709B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099887A1 (en) 2007-02-16 2008-08-21 Eisai R & D Management Co., Ltd. Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
EP2189450B1 (en) 2007-08-17 2011-12-21 Eisai R&D Management Co., Ltd. Method for producing quinazoline derivative
JP5060561B2 (en) 2007-08-17 2012-10-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 New topical preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (en) * 1997-10-17 2001-05-30 Smithkline Beecham Corp USE OF A PDE4 INHIBITOR COMPOUND FOR THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR PRURITE TREATMENT
JPH11209350A (en) 1998-01-26 1999-08-03 Eisai Co Ltd Nitrogen-containing heterocyclic derivative and medicine containing the same

Also Published As

Publication number Publication date
RU2431632C2 (en) 2011-10-20
RS51969B (en) 2012-02-29
PT1992622E (en) 2011-09-19
HK1122025A1 (en) 2009-05-08
TW200812980A (en) 2008-03-16
SI1992622T1 (en) 2011-11-30
KR20080094811A (en) 2008-10-24
CY1112554T1 (en) 2016-02-10
TWI404709B (en) 2013-08-11
DK1992622T3 (en) 2011-09-05
IL193322A (en) 2014-04-30
BRPI0708098B8 (en) 2021-05-25
JO2726B1 (en) 2013-09-15
ES2368089T3 (en) 2011-11-14
KR101278852B1 (en) 2013-07-01
JP4778550B2 (en) 2011-09-21
BRPI0708098B1 (en) 2019-08-06
HRP20110604T1 (en) 2011-09-30
ATE517875T1 (en) 2011-08-15
NZ569936A (en) 2010-07-30
IL193322A0 (en) 2009-05-04
BRPI0708098A2 (en) 2011-05-17
RU2008137654A (en) 2010-03-27
JPWO2007097317A1 (en) 2009-07-16

Similar Documents

Publication Publication Date Title
AR110313A2 (en) DERIVATIVES OF TIAZOL-2-IL-PIRROLIDINA
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
MY158982A (en) Heterocyclic compound
HRP20120323T1 (en) Diarylhydantoin compounds
MY150989A (en) Benzothiazole compounds useful for raf inhibition
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
WO2008083252A3 (en) Methods of use for cyclopamine analogs
WO2009028629A1 (en) Heterocyclic compound and use thereof
AU2006304874A8 (en) Pyrimidinones as casein kinase II (CK2) modulators
MX2009011579A (en) Pyrimidinones as casein kinase ii (ck2) modulators.
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
TNSN08191A1 (en) Kinase inhibitors
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
RS53003B (en) C7-fluoro substituted tetracycline compounds
WO2008019395A3 (en) Compounds for improving learning and memory
RS52255B (en) Nalmefene hydrochloride dihydrate
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2008155666A3 (en) Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
WO2008153129A1 (en) Agent for lowering uric acid level
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
WO2006078984A3 (en) Uses of methylphenidate derivatives
MY146275A (en) 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives